Your browser doesn't support javascript.
loading
Microfluidic Cell Deformability Assay for Rapid and Efficient Kinase Screening with the CRISPR-Cas9 System.
Han, Xin; Liu, Zongbin; Zhao, Li; Wang, Feng; Yu, Yang; Yang, Jianhua; Chen, Rui; Qin, Lidong.
Afiliação
  • Han X; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
  • Liu Z; Department of Cell and Developmental Biology, Weill Medical College of Cornell University, New York, NY, 10065, USA.
  • Zhao L; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
  • Wang F; Department of Cell and Developmental Biology, Weill Medical College of Cornell University, New York, NY, 10065, USA.
  • Yu Y; Department of Molecular and Human Genetics, Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Yang J; Department of Molecular and Human Genetics, Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Chen R; Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Qin L; Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030, USA.
Angew Chem Int Ed Engl ; 55(30): 8561-5, 2016 07 18.
Article em En | MEDLINE | ID: mdl-27258939
ABSTRACT
Herein we report a CRISPR-Cas9-mediated loss-of-function kinase screen for cancer cell deformability and invasive potential in a high-throughput microfluidic chip. In this microfluidic cell separation platform, flexible cells with high deformability and metastatic propensity flowed out, while stiff cells remained trapped. Through deep sequencing, we found that loss of certain kinases resulted in cells becoming more deformable and invasive. High-ranking candidates identified included well-reported tumor suppressor kinases, such as chk2, IKK-α, p38 MAPKs, and DAPK2. A high-ranking candidate STK4 was chosen for functional validation and identified to play an important role in the regulation of cell deformability and tumor suppression. Collectively, we have demonstrated that CRISPR-based on-chip mechanical screening is a potentially powerful strategy to facilitate systematic genetic analyses.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article